On January 7, 2022 Alligator Bioscience (Nasdaq Stockholm: ATORX) reported that Søren Bregenholt, Chief Executive Officer, will participate and host one-on-one investor meetings at the following upcoming investor conferences (Press release, Alligator Bioscience, JAN 7, 2022, View Source [SID1234598399]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright BioConnect Conference, US
Location: Virtual Event

Date: January 10-13

The presentation will be available online – January 10-13, 2022.

Please visit the conference linkto register and view the event.

Redeye Fight Cancer Seminar – Outlook 2022
Location: Virtual Event
Date: Thursday, January 20, 2022
Time: 9:00 – 16:00, company presentation schedule will be updated by Redeye closer to the event and will be live broadcasted at Fight Cancer Seminar – Outlook 2022 | Redeye for Redeye members.

All presentations will be available via a digital library, which is accessible to event participants only. Please contact the organizers to if you wish to attend or Julie Silber if you wish to schedule a meeting with Alligator.